We can become your preferred academic partner and support your innovation-projects in animal health. We combine scientific expertise, knowledge and know-how on animal health with an entrepreneurial organisation of scientists and experienced tech-transfer professionals. Not only that, but thanks to the Industrial Research Fund of Ghent University we have access to proof-of-concept funding, open for collaboration with industry.
Flexibility and tailor-made partnerships
We are receptive to all types of collaborations and partnerships:
out-licensing and development of our UGent-technologies towards the final product
research collaboration on a single project, either bilateral or in a research consortium
strategic partnerships with a specific focus/topic.
All our collaborations and partnerships are supported by a professional business development/tech-transfer team and are based on solid tailor-made agreements on confidentiality, ownership, and exploitation of results.
Social media
Areas of activity
RESEARCH AND DEVELOPMENT
Preclinical researchImmunotherapy developmentCell and Gene therapyVaccine developmentmRNA vaccinesVaccine platformsVaccine adjuvantsVaccine delivery systemsBiomarker discoveryStem cellsTranslational researchInfectious diseases modelling and epidemiologyDiagnostics
CLINICAL DEVELOPMENT AND TRIALS
Clinical trials
DIGITAL HEALTH AND TECHNOLOGY
Digital health toolsNanotechnologyMedical devicesRobotics / AI / Big Data
UGent PROVAXS and the Faculty of Veterinary Medicine accelerate translational research through advanced non-rodent animal models and veterinary patients, enabling predictive pre-clinical studies that strengthen the path toward human clinical applications.
Human health
Animal health
Research & Development
Author
Technology Transfer & Innovation Leader at Ghent University - provaxs
A novel enhanced saRNA platform from Ghent University enables prolonged and efficient therapeutic protein expression with reduced cellular toxicity, supporting safer and more effective vaccines, immunotherapies, and RNA-based medicines.
Immunology
Immunotherapy
Clinical Trials
Preclinical trials
Vaccine Development
Author
Technology Transfer & Innovation Leader at Ghent University - provaxs